Thalassemia is a hereditary blood disorder characterized by defective hemoglobin synthesis resulting in anemia. It is caused by total or partial deficiency in the beta polypeptide chain, impairing hemoglobin and red blood cell production. Symptoms include severe anemia starting at 6 months, bone abnormalities, pallor, jaundice, spleen or liver enlargement, infections, and bleeding tendencies. Complications include fractures, arrhythmias, and heart failure. Diagnosis involves blood tests showing microcytic anemia and high fetal hemoglobin levels. Treatment consists of folic acid, blood transfusions, splenectomy or bone marrow transplantation.
Thalassemia is a hereditary blood disorder characterized by defective hemoglobin synthesis resulting in anemia. It is caused by total or partial deficiency in the beta polypeptide chain, impairing hemoglobin and red blood cell production. Symptoms include severe anemia starting at 6 months, bone abnormalities, pallor, jaundice, spleen or liver enlargement, infections, and bleeding tendencies. Complications include fractures, arrhythmias, and heart failure. Diagnosis involves blood tests showing microcytic anemia and high fetal hemoglobin levels. Treatment consists of folic acid, blood transfusions, splenectomy or bone marrow transplantation.
Thalassemia is a hereditary blood disorder characterized by defective hemoglobin synthesis resulting in anemia. It is caused by total or partial deficiency in the beta polypeptide chain, impairing hemoglobin and red blood cell production. Symptoms include severe anemia starting at 6 months, bone abnormalities, pallor, jaundice, spleen or liver enlargement, infections, and bleeding tendencies. Complications include fractures, arrhythmias, and heart failure. Diagnosis involves blood tests showing microcytic anemia and high fetal hemoglobin levels. Treatment consists of folic acid, blood transfusions, splenectomy or bone marrow transplantation.
Thalassemia is a hereditary blood disorder characterized by defective hemoglobin synthesis resulting in anemia. It is caused by total or partial deficiency in the beta polypeptide chain, impairing hemoglobin and red blood cell production. Symptoms include severe anemia starting at 6 months, bone abnormalities, pallor, jaundice, spleen or liver enlargement, infections, and bleeding tendencies. Complications include fractures, arrhythmias, and heart failure. Diagnosis involves blood tests showing microcytic anemia and high fetal hemoglobin levels. Treatment consists of folic acid, blood transfusions, splenectomy or bone marrow transplantation.
Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1of 9
Thalassemia
Rajesh Kumar Sharma
Lecture Himalayan College of Nursing Thalassemia It is a hereditary group of hemolytic anemia's, is characterized by defective synthesis in polypeptide chains of the protein component of hemoglobin. Consequently, RBC synthesis is also impaired. Causes:- Homozygous or heterozygous inharitance Pathophysiology Total or partial deficiency of beta polypeptide chain production impairs hemoglobin synthesis and results in continual production of fetal hemoglobin. Normally, immunoglobulin synthesis switches at birth time. This conversion does not happen in thalassemic infants. Their red cells are hypochromic and microcytic. Sign & symptoms Sever anemia @ 6 months of life Bone abnormalities Pallor Yellowish skin Splenomegaly or hepatomegaly Frequent infection Bleeding tendencies Small body & large head Possibly mental retardation Complications Pathological fracture Cardiac arrhythmias Heart failure Diagnosis CBC Microcytosis Long bones X-ray Fetal Hb level Treatment Folic acid supplement Transfusion of Packed cells Splenectomy & bone marrow transplantation Nursing considerations
Fast Facts: Deficit di piruvato chinasi per pazienti e sostenitori: Una rara malattia genetica che colpisce I globuli rossi Informazioni + assunzione del controllo = migliore risultato